Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon

Objective: This study was designed to determine the efficacy of ivermectin, an FDA-approved drug, in producing clinical benefits and decreasing the viral load of SARS-CoV-2 among asymptomatic subjects that tested positive for this virus in Lebanon. Methods: A randomized controlled trial was conducte...

Descripción completa

Detalles Bibliográficos
Autores principales: Samaha, Ali A., Mouawia, Hussein, Fawaz, Mirna, Hassan, Hamad, Salami, Ali, Bazzal, Ali Al, Saab, Hamid Bou, Al-Wakeel, Mohamed, Alsaabi, Ahmad, Chouman, Mohamad, Moussawi, Mahmoud Al, Ayoub, Hassan, Raad, Ali, Hajjeh, Ola, Eid, Ali H., Raad, Houssam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226630/
https://www.ncbi.nlm.nih.gov/pubmed/34073401
http://dx.doi.org/10.3390/v13060989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226630/
https://www.ncbi.nlm.nih.gov/pubmed/34073401
http://dx.doi.org/10.3390/v13060989

Ejemplares similares